Literature DB >> 7509965

Endothelins 1 and 3 and big endothelin-1 contract isolated human placental veins.

J V Mombouli1, S Q Le, N Wasserstrum, P M Vanhoutte.   

Abstract

Experiments were designed to investigate the reactivity of vascular smooth muscle to endothelins (ETs) in veins taken from human placentas immediately after delivery. The placental veins were cut into rings and suspended between two stirrups in conventional organ chambers (filled with aerated, modified Krebs-Ringer bicarbonate solution) for isometric recording of tension. ET-1 and ET-3 caused concentration-dependent contractions of the isolated human placental veins. The responses induced by ET-1 were greater than those evoked by ET-3 and were not significantly affected by BQ-123, a selective inhibitor of ETA receptors. Contractions to big ET-1 were obtained in rings both with and without endothelium; they were inhibited by phosphoramidon, an inhibitor of endothelin-converting enzyme. These findings indicate that the conversion of the precursor of ET-1 can occur in human placental veins. The receptors mediating the contraction of human placental veins to endothelins do not belong to the ETA subtype; the response to the peptides is probably mediated in part by an uncharacterized ET-receptor subtype and in part by ETB receptors. The output of big ET-1 in the vascular wall or from surrounding tissues in the placenta could be involved in the regulation of venous tone in this organ.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7509965     DOI: 10.1097/00005344-199322008-00073

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

1.  Positron emission tomography of [18F]-big endothelin-1 reveals renal excretion but tissue-specific conversion to [18F]-endothelin-1 in lung and liver.

Authors:  Peter Johnström; Tim D Fryer; Hugh K Richards; Janet J Maguire; John C Clark; John D Pickard; Anthony P Davenport
Journal:  Br J Pharmacol       Date:  2010-02       Impact factor: 8.739

2.  Phosphoramidon inhibition of the in vivo conversion of big endothelin-1 to endothelin-1 in the human forearm.

Authors:  C Plumpton; W G Haynes; D J Webb; A P Davenport
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

Review 3.  Uteroplacental circulation and fetal vascular function and development.

Authors:  Kent L Thornburg; Samantha Louey
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

4.  First-in-Man Demonstration of Direct Endothelin-Mediated Natriuresis and Diuresis.

Authors:  Robert W Hunter; Rebecca Moorhouse; Tariq E Farrah; Iain M MacIntyre; Takae Asai; Peter J Gallacher; Debbie Kerr; Vanessa Melville; Alicja Czopek; Emma E Morrison; Jess R Ivy; James W Dear; Matthew A Bailey; Jane Goddard; David J Webb; Neeraj Dhaun
Journal:  Hypertension       Date:  2017-05-15       Impact factor: 10.190

5.  Truncated human endothelin receptor A produced by alternative splicing and its expression in melanoma.

Authors:  Y F Zhang; S Jeffery; S A Burchill; P A Berry; J C Kaski; N D Carter
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.